Terazosin hydrochloride Catalog No.:M17080-C 11(11):978

11(11):978

with neuroprotective and anti-apoptotic effects

InChi: InChI=1S/C113H157N31O32/c1-58(2)40-76(109(172)144-93(60(5)6)110(173)139-79(42-63-22-13-9-14-23-63)104(167)141-84(112(175)176)44-64-24-15-10-16-25-64)134-97(160)71(26-17-18-38-114)130-99(162)73(32-35-86(116)147)132-105(168)80(45-66-50-119-55-124-66)137-107(170)82(47-68-52-121-57-126-68)140-111(174)92(59(3)4)143-101(164)75(34-37-89(151)152)133-102(165)77(43-65-28-30-69(146)31-29-65)128-87(148)53-123-96(159)85(54-145)142-108(171)83(49-91(155)156)138-106(169)81(46-67-51-120-56-125-67)136-98(161)72(27-19-39-122-113(117)118)131-103(166)78(41-62-20-11-8-12-21-62)135-100(163)74(33-36-88(149)150)129-94(157)61(7)127-95(158)70(115)48-90(153)154/h8-16

with IC50s of 14 nM and 11 nM

Terazosin hydrochloride Catalog No.:M17080-C 11(11):978Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active 1 adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment. Product information CAS Number: 63074 08 8 Molecular Weight: 423. 89 Formula: C19H26ClN5O4 Chemical Name: 6,7 dimethoxy 2 [4 (oxolane 2